Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 07 2022
Historique:
received: 28 07 2021
accepted: 05 07 2022
entrez: 15 7 2022
pubmed: 16 7 2022
medline: 20 7 2022
Statut: epublish

Résumé

Several studies investigated the effectiveness and the safety of different doses of pregabalin in fibromyalgia. However, the optimal protocol remains controversial. A Bayesian network meta-analysis comparing 300, 450, and 600 mg/daily of pregabalin for fibromyalgia was conducted. The literature search was conducted in January 2022. All the double-blind randomised clinical trials comparing two or more dose protocols of pregabalin for fibromyalgia were accessed. Studies enrolling less than 50 patients were not eligible, nor were those with a length of follow-up shorter than eight weeks. The outcomes of interests were: Fibromyalgia Impact Questionnaire (FIQ), sleep quality, and adverse events. The network meta-analyses were performed using the routine for Bayesian hierarchical random-effects model analysis, with log odd ratio (LOR) and standardized mean difference (SMD) effect measure. Data from 4693 patients (mean age 48.5 years) were retrieved. 93.1% (4370 of 4693 patients) were women. The median follow-up was 14.8 weeks. Pregabalin 450 mg/daily resulted in greater reduction in Fibromyalgia Impact Questionnaire (SMD - 1.83). Pregabalin 600 demonstrated the greatest sleep quality (SMD 0.15). Pregabalin 300 mg/daily evidenced the lowest rate of adverse events (LOR 0.12). The dose of pregabalin must be customised according to patients' characteristics and main symptoms.

Identifiants

pubmed: 35840702
doi: 10.1038/s41598-022-16146-x
pii: 10.1038/s41598-022-16146-x
pmc: PMC9287452
doi:

Substances chimiques

Analgesics 0
Pregabalin 55JG375S6M
gamma-Aminobutyric Acid 56-12-2

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12148

Informations de copyright

© 2022. The Author(s).

Références

J Rheumatol. 2011 Dec;38(12):2643-52
pubmed: 21965636
Drug Healthc Patient Saf. 2016 Feb 17;8:13-23
pubmed: 26937205
Pain Pract. 2011 Nov-Dec;11(6):516-27
pubmed: 21199320
J Rheumatol. 2004 Jun;31(6):1193-9
pubmed: 15170935
Pain Res Manag. 2020 Feb 11;2020:6541798
pubmed: 32104521
J Phys Ther Sci. 2014 Oct;26(10):1561-5
pubmed: 25364113
Neuropsychiatr Dis Treat. 2008 Dec;4(6):1193-201
pubmed: 19337459
Rheumatol Int. 2016 May;36(5):663-72
pubmed: 27000046
Am J Phys Med Rehabil. 2016 Oct;95(10):738-45
pubmed: 27003201
Pain Manag. 2016 May;6(4):383-400
pubmed: 27306300
Pain. 2008 Jun;136(3):419-431
pubmed: 18400400
Curr Opin Pharmacol. 2006 Feb;6(1):108-13
pubmed: 16376147
Am J Med Sci. 1998 Jun;315(6):367-76
pubmed: 9638893
Clin Rheumatol. 2017 Jul;36(7):1623-1630
pubmed: 28299460
Pain. 2016 Jul;157(7):1532-40
pubmed: 26982602
Pain Res Treat. 2012;2012:426130
pubmed: 23213512
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
pubmed: 20526405
Curr Med Res Opin. 2014 Oct;30(10):2069-83
pubmed: 24867298
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Mayo Clin Proc. 2015 May;90(5):680-92
pubmed: 25939940
Ann Rheum Dis. 2017 Feb;76(2):318-328
pubmed: 27377815
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD007076
pubmed: 19588419
J Pain. 2008 Sep;9(9):792-805
pubmed: 18524684
J Orthop. 2020 Jan 13;20:257-260
pubmed: 32127730
Epidemiol Health. 2017 Oct 27;39:e2017047
pubmed: 29092392
Sleep Med. 2009 Jun;10(6):604-10
pubmed: 19410509
Pain Med. 2016 Nov;17(11):2100-2108
pubmed: 27257288
Clin Ther. 2012 May;34(5):1092-102
pubmed: 22503162
Ann Intern Med. 2020 Mar 3;172(5):ITC33-ITC48
pubmed: 32120395
Semin Arthritis Rheum. 2011 Dec;41(3):335-45.e6
pubmed: 21868065
J Rheumatol. 1994 Jun;21(6):1113-7
pubmed: 7932424
Pain. 2009 Sep;145(1-2):69-81
pubmed: 19539427
Rheumatology (Oxford). 2010 Apr;49(4):706-15
pubmed: 20056767
Arthritis Res Ther. 2013;15(6):221
pubmed: 24289848
Curr Med Res Opin. 2016;32(3):601-9
pubmed: 26694975
J Rheumatol. 2015 Jul;42(7):1237-44
pubmed: 26034150
J Pain Res. 2010 Jun 22;3:81-8
pubmed: 21197312
Arthritis Rheum. 2005 Apr;52(4):1264-73
pubmed: 15818684
Arthritis Rheum. 2009 Oct;60(10):3146-52
pubmed: 19790053
J Rheumatol. 2008 Mar;35(3):502-14
pubmed: 18278830

Auteurs

Filippo Migliorini (F)

Department of Orthopaedic, Trauma, and Reconstructive Surgery, RWTH Aachen University Clinic, Pauwelsstraße 30, 52074, Aachen, Germany. migliorini.md@gmail.com.

Nicola Maffulli (N)

Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081, Baronissi, SA, Italy.
School of Pharmacy and Bioengineering, Keele University School of Medicine, Thornburrow Drive, Stoke on Trent, England.
Barts and the London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, Mile End Hospital, Queen Mary University of London, 275 Bancroft Road, London, E1 4DG, England.

Matthias Knobe (M)

Department of Orthopedics and Trauma Surgery, Lucerne Cantonal Hospital, Lucerne, Switzerland.

Giacomo Tenze (G)

Department of Emergency Urgency Intensive Care Unit, University Clinic Tor Vergata, 00133, Rome, Italy.

Ali Aljalloud (A)

Department of Cardiothoracic Surgery, RWTH Aachen University Clinic, 52074, Aachen, Germany.

Giorgia Colarossi (G)

Department of Cardiothoracic Surgery, RWTH Aachen University Clinic, 52074, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH